Technology Innovation Institute, Burjeel Medical City Partner to Advance Immunotherapy Solutions for Cancer Patients
Stay Updated with the Latest Developments at Burjeel Medical City
Technology Innovation Institute, Burjeel Medical City Partner to Advance Immunotherapy Solutions for Cancer Patients
Synergy promises to redefine oncology therapy and drive personalized treatment for cancer patients
Abu Dhabi-UAE: 15, 05, 2024 – In line with the UAE’s ongoing efforts to revolutionize cancer care, the Technology Innovation Institute (TII), a leading global scientific research center and the applied research pillar of Abu Dhabi’s Advanced Technology Research Council (ATRC), today announced that it has joined forces with Burjeel Medical City (BMC), the flagship quaternary care hospital under Burjeel Holdings, to pioneer novel immunotherapy solutions for cancer treatment. The collaboration is focused on engineering T-cell based therapeutics, including Chimeric Antigen Receptor T (CAR-T) cell therapy and Tumor-Infiltrating Lymphocyte (TIL) therapy – two groundbreaking treatments that help boost the body’s own immune system to fight against cancer.
The partnership, set to run for two years with the possibility of further extension, was signed by Dr. Thomas Launey, Chief Researcher of TII’s Biotechnology Research Center, and Dr. Khaled Musallam, Chief Research Officer of Burjeel Holdings, in the presence of Dr. Ray O. Johnson, CEO, TII, and Safeer Ahamed, Group COO, Burjeel Holdings, at the Abu Dhabi Global Healthcare Week. BMC, known for its complex care offerings in key specialties including oncology, will leverage cutting-edge technologies from TII, such as its state-of-the-art computational framework to identify patient-specific antigens relevant to cancer, and develop personalized cancer therapies. In Phase 1 of the project, TII will construct an in-silico platform to identify tailored cancer-specific antigens from single-cell transcriptomics data. This platform will facilitate the design of CAR-T cells capable of effectively targeting cancer-specific antigens. During Phase 2, the in-silico platform will undergo rigorous testing through in-vitro and in-vivo experiments.
Dr. Thomas Launey, said: “We expect that this collaboration with BMC will yield fast and meaningful impact in cancer therapy. Together, we are committed to pushing the boundaries of innovation to provide hope to those affected by this critical health challenge.”
Dr. Khaled Musallam, said, “We live in times where cancers continue to proliferate with a ruthless and growing frequency, impacting the lives of those affected and their families. This is clearly not a struggle the healthcare sector can overcome alone. Creating partnerships that help supercharge cancer research and treatment are crucial to enhance the pace of discoveries and improve patient outcomes. Our partnership with TII will play a pivotal role in the ongoing fight against cancer.”
With the UAE fast becoming a key leader in innovative cancer care through various strategic initiatives, the TII-Burjeel alliance is a clear indication of the country’s commitment to collaborative progress in oncology, fostering breakthrough solutions that will elevate the healthcare industry to new heights.
# # #
About Technology Innovation Institute (TII)
The Technology Innovation Institute (TII) is the dedicated applied research pillar of Abu Dhabi’s Advanced Technology Research Council (ATRC). TII is a pioneering global research and development center that focuses on applied research and new-age technology capabilities. The Institute has 10 dedicated research centers in advanced materials, autonomous robotics, cryptography, AI and digital science, directed energy, quantum, secure systems, propulsion and space, biotechnology, and renewable and sustainable energy. By working with exceptional talent, universities, research institutions, and industry partners from all over the world, TII connects an intellectual community and contributes to building an R&D ecosystem that reinforces the status of Abu Dhabi and the UAE as a global hub for innovation.
For more information, visit https://www.tii.ae/
Connect with us on social media:
LinkedIn: https://www.linkedin.com/company/tiiuae/
Twitter: https://twitter.com/TIIuae
Instagram: https://www.instagram.com/tiiuae/
For media inquiries, please contact:
Technology Innovation Institute
About Burjeel Medical City
Burjeel Medical City (BMC) is a 400-bed multispecialty hospital and quaternary care center located in Abu Dhabi, UAE. It is the region’s complex care hub with over 60 adult and pediatric specialties, aided by state-of-the-art medical technology and an international team of experts. The 1.2 million-square-foot hospital is a flagship facility under the Burjeel Holdings umbrella. It is renowned for key specialties including oncology, hematology, bone marrow transplantation, neurosurgery, multi-organ transplantation, advanced orthopedic surgery, pediatric subspecialties, fetal medicine, nuclear medicine, and advanced gynecology. The hospital is the first to receive ESMO accreditation as an Integrated Oncology and Palliative Care Center. BMC is the Reference Site for Elekta and Novalis Certified Radiosurgery Centers. Visit: https://burjeelmedicalcity-stage.burjeelholdings.com/
Connect with us on social media:
LinkedIn: https://www.linkedin.com/company/burjeel-medical-city/
Twitter: https://x.com/burjeelmedicity
Instagram: https://instagram.com/burjeelmedicity
Facebook: https://www.facebook.com/BurjeelMediCity
For media inquiries, please contact:
M Unnikrishnan, Corporate Communications Officer, Burjeel Holdings
krish@burjeelholdings.com
Abu Dhabi Doctors Successfully Diagnose and Treat One-in-a-Million Rare Disease
The patient, treated at Burjeel Hospital, Abu Dhabi, suffered from Adult-Onset Still’s Disease (AOSD),
Under the Supervision of Department of Health – Abu Dhabi Administers Novel Precision Therapy to First Patient Worldwide with Advanced Breast Cancer at Burjeel Cancer Institute
Abu Dhabi, UAE, xx June 2026 - Abu Dhabi has marked a global milestone achievement by becoming the
Strengthening Community Health and Workforce Safety, Lifecare Hospital Launches Seasonal Illness Clinic to Enhance Prevention and Early Detection
The clinic provides specialized care to support early diagnosis and effective treatment
Burjeel Medical City Launches Specialized Sleep Clinic to Enhance Quality of Life and Community Well-Being
The clinic provides comprehensive diagnosis and treatment of common and underdiagnosed sleep
First Uniportal Robotic Lobectomy Performed on 37‑Year‑Old Stage One Lung Cancer Patient
A minimally invasive surgery at Burjeel Medical City removed part of the
UAE Frontline Healthcare Workers Set Guinness World Record for ‘Most Nationalities Carrying a Banner’ in Solidarity with the Nation
In spite of rain, Burjeel Holdings’ frontline healthcare workers from 64 nationalities united under one
Burjeel Medical City Launches Sarcoma & Bone Center to Strengthen Care for Rare and Complex Cancers
New multidisciplinary center at Burjeel Cancer Institute integrates oncology, orthopedic surgery, and
Left Hand in the Right Hands: Abu Dhabi Doctors Save Man’s Arm After Complete Amputation Through a 10-Hour Complex Microsurgery
Specialists at Burjeel Medical City replanted the patient’s arm that was caught in a